Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
Status:
Completed
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
To prospectively evaluate the short-term efficacy and toxicity of induction chemotherapy with
cisplatin and capecitabine followed by concurrent chemoradiotherapy (CCRT) in the treatment
of locally advanced nasopharyngeal carcinoma.